Inflammation, coagulation and risk of locomotor disability in elderly women: Findings from the british women's heart and health study

European Journal of Epidemiology

Volumn 27, Issue 8, 2012, Pages 633-645

  Nüesch, Eveline ^a   Dale, Caroline E ^a   Amuzu, Antoinette ^a   Kuper, Hannah ^a   Bowling, Ann ^b   Ploubidis, George B ^a   Lowe, Gordon ^c   Rumley, Ann ^c   Ebrahim, Shah ^a,d   Casas, Juan P ^a,e  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KINGSTON UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aging; Blood coagulation; Inflammation; Locomotor disability

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; INTERLEUKIN 6; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; AGING; ARTICLE; BLOOD CLOTTING; BLOOD VISCOSITY; BRITISH; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; ETHNIC GROUP; FEMALE; HEALTH STATUS; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LIFESTYLE; LOCOMOTION; LOCOMOTOR DISABILITY; MAJOR CLINICAL STUDY; MUSCULOSKELETAL DISEASE; ONSET AGE; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SELF REPORT; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; WOMEN'S HEALTH;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD COAGULATION; CHRONIC DISEASE; DISABLED PERSONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; INFLAMMATION; LIFE STYLE; LOCOMOTION; MALE; MOTOR ACTIVITY; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SELF REPORT; SOCIOECONOMIC FACTORS;

EID: 84866522204     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9706-6     Document Type: Article

References (41)

1. Stuck AE, Walthert JM, Nikolaus T, Bula CJ, Hohmann C, Beck JC. Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med. 1999;48(4):445-69.
2. Ebrahim S, Wannamethee SG, Whincup P, Walker M, Shaper AG. Locomotor disability in a cohort of British men: the impact of lifestyle and disease. Int J Epidemiol. 2000;29(3):478-86.
3. Rautio N, Adamson J, Heikkinen E, Ebrahim S. Associations of socio-economic position and disability among older women in Britain and Jyvaskyla, Finland. Arch Gerontol Geriatr. 2006;42(2):141-55.
4. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009;8(1):18-30.
5. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev. 2011;10(3):319-29.
6. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med. 2003;114(3):180-7.
7. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47(6):639-46.
8. Penninx BW, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S, et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc. 2004;52(7): 1105-13.
9. Kuo HK, Bean JF, Yen CJ, Leveille SG. Linking C-reactive protein to late-life disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002. J Gerontol A Biol Sci Med Sci. 2006;61(4):380-7.
10. Brinkley TE, Leng X, Miller ME, Kitzman DW, Pahor M, Berry MJ, et al. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci. 2009;64(4):455-61.
11. Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams g, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59(3):242-8.
12. McDermott MM, Guralnik JM, Greenland P, Green D, Liu K, Ridker PM, et al. Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease. J Am Geriatr Soc. 2004;52(11):1888-94.
13. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002;57(5):M326-32.
14. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002;162(20):2333-41.
15. Barzilay JI, Blaum C, Moore T, Xue QL, Hirsch CH, Walston JD, et al. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med. 2007;167(7):635-41.
16. Reiner AP, Aragaki AK, Gray SL, Wactawski-Wende J, Cauley JA, Cochrane BB, et al. Inflammation and thrombosis biomarkers and incident frailty in postmenopausal women. Am J Med. 2009;122(10):947-54.
17. Lawlor DA, Bedford C, Taylor M, Ebrahim S. Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study. J Epidemiol Community Health. 2003;57(2):134-40.
18. Adamson J, Lawlor DA, Ebrahim S. Chronic diseases, locomotor activity limitation and social participation in older women: cross sectional survey of British Women's Heart and Health Study. Age Ageing. 2004;33(3):293-8.
19. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297-334.
20. Gaunt TR, Lowe GDO, Lawlor DA, Casas JP, Day INM. A genecentric analysis of activated partial thromboplastin time and activated protein C resistance using the Human CVD focused genotyping array (submitted).
21. Jefferis BJ, Lowe GD, Welsh P, Rumley A, Lawlor DA, Ebrahim S, et al. Secondhand smoke (SHS) exposure is associated with circulating markers of inflammation and endothelial function in adult men and women. Atherosclerosis. 2010;208(2):550-6.
22. Lawlor DA, Davey Smith G, Patel R, Ebrahim S. Life-course socioeconomic position, area deprivation, and coronary heart disease: findings from the British Women's Heart and Health Study. Am J Public Health. 2005;95(1):91-7.
23. Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med. 2008;5(1):e12.
24. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol. 1992;45(10): 1101-9.
25. EuroQol Group. EQ-5D: a standardised instrument for use as a measure of health outcome. 2007. http://www.euroqol.org.
26. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337-43.
27. Tas U, Verhagen AP, Bierma-Zeinstra SM, Hofman A, Odding E, Pols HA, et al. Incidence and risk factors of disability in the elderly: the Rotterdam Study. Prev Med. 2007;44(3):272-8.
28. Royston P. Multiple imputation of missing values. Stata J. 2004;4:227-41.
29. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
30. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4:87-9.
31. Ebrahim S, Davey Smith G. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet. 2008;123(1):15-33.
32. Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33(1):30-42.
33. Adamson J, Beswick A, Ebrahim S. Is stroke the most common cause of disability? J Stroke Cerebrovasc Dis. 2004;13(4):171-7.
34. Martin J, Meltzer H, Elliot D. The prevalence of disability among adults: OPCS surveys of disability in Great Britain. London: HMSO; 1988.
35. International Classification of Functioning, Disability and Health. 2001.
36. Penninx BW, Abbas H, Ambrosius W, Nicklas BJ, Davis C, Messier SP, et al. Inflammatory markers and physical function among older adults with knee osteoarthritis. J Rheumatol. 2004;31(10):2027-31.
37. Jefferis BJ, Whincup PH, Welsh P, Wannamethee SG, Rumley A, Lennon LT, et al. Circulating TNFalpha levels in older men and women do not show independent prospective relations with MI or stroke. Atherosclerosis. 2009;205(1):302-8.
38. Colbert LH, Visser M, Simonsick EM, Tracy RP, Newman AB, Kritchevsky SB, et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2004;52(7): 1098-104.
39. Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 2002;105(15):1785-90.
40. Jankord R, Jemiolo B. Influence of physical activity on serum IL-6 and IL-10 levels in healthy older men. Med Sci Sports Exerc. 2004;36(6):960-4.
41. Miller GD, Nicklas BJ, Loeser RF. Inflammatory biomarkers and physical function in older, obese adults with knee pain and selfreported osteoarthritis after intensive weight-loss therapy. J Am Geriatr Soc. 2008;56(4):644-51.